Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02BE01	SULDEX B	G	Paracetamol - 150mg	150mg	Suppository	117,746 L.L
J02AC01	STABILANOL	G	Fluconazole - 150mg	150mg	Capsule	264,637 L.L
L04AC18	SKYRIZI	BioTech	Risankizumab - 150mg	150mg	Injectable solution	194,911,251 L.L
M03BX04	STIFFANO	G	Tolperisone - 150mg	150mg	Tablet	651,764 L.L
B05XA05	SULFATE DE MAGNESIUM RENAUDIN	G	Magnesium sulfate - 1.5g/10ml	15%	Injectable solution	434,061 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	235,593,517 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	L.L
D06BA05	SULFANILAMIDE	G	Sulfanilamide - 12g	12g	Powder	151,022 L.L
J01DD15	SEFARIN	G	Cefdinir - 125mg/5ml	125mg/5ml	Suspension	1,695,929 L.L
J01DD15	SEFARIN	G	Cefdinir - 125mg/5ml	125mg/5ml	Suspension	939,346 L.L
N02BE01	SULDEX 125	G	Paracetamol - 125mg	125mg	Suppository	110,067 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 120mg	120mg	Injectable solution	57,492,826 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 120mg	120mg	Injectable solution	L.L
M04AA03	STABURIC	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,420,889 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 850mg	12.5mg/850mg	Tablet, film coated	3,287,711 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 1000mg	12.5mg/1000mg	Tablet, film coated	3,399,653 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 1000mg	12.5mg/1000mg	Tablet, film coated	3,399,653 L.L
N06AB05	SEROXAT CR	B	Paroxetine (HCl) - 12.5mg	12.5mg	Tablet, controlled release	2,371,608 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 12.5mg	12.5mg	Capsule	L.L
L01EX01	SUTENT	B	Sunitinib maleate - 12.5mg	12.5mg	Capsule	54,006,801 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 12.5mg	12.5mg	Capsule	36,042,560 L.L
L01EX01	SUNITINIB AQVIDA	G	Sunitinib maleate - 12.5mg	12.5mg	Capsule, hard	35,585,027 L.L
N02BE01	SUPOFEN	G	Paracetamol - 10mg/ml	10mg/ml	Injectable solution	7,675,286 L.L
D11AX22	SOOLANTRA	B	Ivermectin - 10mg/g	10mg/g	Cream	2,154,180 L.L
D11AX22	SOOLANTRA	B	Ivermectin - 10mg/g	10mg/g	Cream	1,053,573 L.L
D06BA01	SILVEDERMA	G	Silver sulfadiazine - 1%	10mg/g	Cream	1,220,209 L.L
D06BA01	SILVEDERMA	G	Silver sulfadiazine - 1%	10mg/g	Cream	494,534 L.L
C10AA05	STORVAS	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	362,837 L.L
G04BD08	SOLIFAS	G	Solifenacin succinate - 10mg	10mg	Tablet, film coated	971,598 L.L
G04BD08	SOLIFENACINE ARROW	G	Solifenacin succinate - 10mg	10mg	Tablet	952,784 L.L

...